312 related articles for article (PubMed ID: 26097592)
1. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
Karahan B; Argon A; Yıldırım M; Vardar E
Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of colorectal adenocarcinomas at single-institution with respect to microsatellite instability.
Ozkara S; Sari B; Yesil A; Aktekin A; Sezikli M; Cetinkaya Z; Aker F
Chirurgia (Bucur); 2013; 108(4):473-7. PubMed ID: 23958088
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
4. [Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma].
Raskin GA; Ianus GA; Kornilov AV; Orlova RV; Petrov SV; Protasova AÉ; Pozharisskiĭ KM; Imianitov EN
Vopr Onkol; 2014; 60(2):47-50. PubMed ID: 24919261
[TBL] [Abstract][Full Text] [Related]
5. Mismatch Repair Protein Expression in Clear Cell Carcinoma of the Ovary: Incidence and Morphologic Associations in 109 Cases.
Bennett JA; Morales-Oyarvide V; Campbell S; Longacre TA; Oliva E
Am J Surg Pathol; 2016 May; 40(5):656-63. PubMed ID: 26813747
[TBL] [Abstract][Full Text] [Related]
6. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.
Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N
Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624
[TBL] [Abstract][Full Text] [Related]
7. The pathological phenotype of colon cancer with microsatellite instability.
Andersen HS; Bertelsen CA; Henriksen R; Campos AH; Kristensen B; Ingeholm P; Gögenur I
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836800
[TBL] [Abstract][Full Text] [Related]
8. [Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes].
Kuligina ESh; Morreau N; Imianitov EN
Vopr Onkol; 2010; 56(2):152-5. PubMed ID: 20552889
[TBL] [Abstract][Full Text] [Related]
9. Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!
Fadhil W; Field J; Cross G; Kaye P; Ilyas M
Histopathology; 2012 Sep; 61(3):522-5. PubMed ID: 22642480
[No Abstract] [Full Text] [Related]
10. Interpretation of immunohistochemistry for mismatch repair proteins is only reliable in a specialized setting.
Overbeek LI; Ligtenberg MJ; Willems RW; Hermens RP; Blokx WA; Dubois SV; van der Linden H; Meijer JW; Mlynek-Kersjes ML; Hoogerbrugge N; Hebeda KM; van Krieken JH
Am J Surg Pathol; 2008 Aug; 32(8):1246-51. PubMed ID: 18677806
[TBL] [Abstract][Full Text] [Related]
11. Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation.
Gill S; Lindor NM; Burgart LJ; Smalley R; Leontovich O; French AJ; Goldberg RM; Sargent DJ; Jass JR; Hopper JL; Jenkins MA; Young J; Barker MA; Walsh MD; Ruszkiewicz AR; Thibodeau SN
Clin Cancer Res; 2005 Sep; 11(18):6466-71. PubMed ID: 16166421
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples?
Shia J; Stadler Z; Weiser MR; Rentz M; Gonen M; Tang LH; Vakiani E; Katabi N; Xiong X; Markowitz AJ; Shike M; Guillem J; Klimstra DS
Am J Surg Pathol; 2011 Mar; 35(3):447-54. PubMed ID: 21297438
[TBL] [Abstract][Full Text] [Related]
13. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
15. Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome.
Jessup CJ; Redston M; Tilton E; Reimann JD
Hum Pathol; 2016 Mar; 49():1-9. PubMed ID: 26826402
[TBL] [Abstract][Full Text] [Related]
16. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
Usha L; Dewdney SB; Buckingham LE
JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
[No Abstract] [Full Text] [Related]
17. High-level microsatellite instability in appendiceal carcinomas.
Taggart MW; Galbincea J; Mansfield PF; Fournier KF; Royal RE; Overman MJ; Rashid A; Abraham SC
Am J Surg Pathol; 2013 Aug; 37(8):1192-200. PubMed ID: 23648460
[TBL] [Abstract][Full Text] [Related]
18. Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.
Panarelli NC; Vaughn CP; Samowitz WS; Yantiss RK
Am J Surg Pathol; 2015 Mar; 39(3):313-7. PubMed ID: 25602793
[TBL] [Abstract][Full Text] [Related]
19. Heterogenous mismatch-repair status in colorectal cancer.
Joost P; Veurink N; Holck S; Klarskov L; Bojesen A; Harbo M; Baldetorp B; Rambech E; Nilbert M
Diagn Pathol; 2014 Jun; 9():126. PubMed ID: 24968821
[TBL] [Abstract][Full Text] [Related]
20. Optimization of antibodies for detection of the mismatch repair proteins MLH1, MSH2, MSH6, and PMS2 using a biotin-free visualization system.
Hansen TP; Nielsen O; Fenger C
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):115-21. PubMed ID: 16540742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]